I understand why this is a foreign concept to you, given you've parked your money in a company with no prospects to deliver a commercially viable solution to assist patients in desperate need of life-saving treatment.
I get it ... so when CYP treats patients with GVHD 'with mortality rates in excess of 90 percent' (Ross's words from May 2022 CYP announcement) I guess it is life saving but when Mesoblast do the same with great results not so much "life saving" ... my bad
Oh and the world’s biggest killer is ischaemic heart disease - just sayin'
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)